|
CA2879557A1
|
|
Methods, kits and compositions for providing a clinical assessment of prostate cancer
|
|
EP2677036A2
|
|
Method for predicting the risk of cancer recurrence
|
|
WO2006056080A1
|
|
Gpx2 a specific and sensitive target for lung cancer diagnosis, prognosis and/or theranosis
|
|
WO2006053442A1
|
|
Calml3 a specific and sensitive target for lung cancer diagnosis, prognosis and/or theranosis
|
|
AU2004209578A1
|
|
Method to detect prostate cancer in a sample
|
|
US7368545B1
|
|
PCA3 messenger RNA species in benign and malignant prostate tissues
|
|
AU4373297A
|
|
Polyethyleneglycol conjugated nanoerythrosomes, method of making same and use thereof
|
|
AU4373197A
|
|
Recombinant single chain antibodies directed against the gp54 cancer marker, composition comprising same and use thereof
|
|
WO9812564A1
|
|
Immunological composition for detection of bladder cancer and method of using same
|
|
US6197935B1
|
|
Prion-free collagen and collagen-derived products and implants for multiple biomedical applications; methods of making thereof
|
